Company profile: MiMedx
1.1 - Company Overview
Company description
- Provider of wound care and therapeutic biologics, offering human amniotic membrane and umbilical cord allografts for wound care (including diabetic foot ulcers and venous leg ulcers) and surgical applications. Products include EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, AMNIOBURN for burn care, and AXIOFILL, a biocompatible acellular human placental extracellular matrix to replace or supplement damaged or inadequate integumental tissue.
Products and services
- AMNIOFIX: Human amniotic membrane allograft used in surgical applications to reduce inflammation and enhance healing
- AXIOFILL: Acellular human placental extracellular matrix utilized to replace or supplement damaged or inadequate integumental tissue
- EPIFIX: Dehydrated human amnion/chorion membrane applied to wound care, including diabetic foot ulcers and venous leg ulcers
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MiMedx
Kerecis
HQ: Iceland
Website
- Description: Provider of patented fish-skin and fatty acid-based products for cellular therapy, regenerative medicine, and wound/surgical care, including Kerecis Omega3 Wound, Omega3 SurgiClose, Omega3 SurgiBind, Omega3 GraftGuide, WOUND spray, and 1 Primary Wound Dressing spray; gently processed fish skin retains human skin-like structure with no disease-transfer risk from cold-water fish.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kerecis company profile →
Triad Life Sciences
HQ: United States
Website
- Description: Provider of regenerative medicine technologies based on placental-derived extracellular matrix for managing acute, traumatic, hard-to-heal and surgical wounds and burns. Offers InnovaMatrix AC and PD wound devices, InnovaBurn for partial-thickness burns, and the proprietary TriCleanse decellularization process, plus InnovaMatrix Reimbursement services for insurance verification, coding/billing, and prior authorization support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triad Life Sciences company profile →
Lynch Biologics
HQ: United States
Website
- Description: Provider of biotechnology health care, located in Franklin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lynch Biologics company profile →
Artelon
HQ: United States
Website
- Description: Provider of bio-textile solutions for kinematic reinforcement of tendon and ligament reconstruction, developing synthetic materials for tissue reconstruction and restoring stability and motion. Products include FLEXBAND biomaterial and systems (Twist, Solo, Multi, FIX), FLEXBAND Plus, FLEXPATCH, Dynamic Matrix Technology used in over 60,000 implantations, and educational programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artelon company profile →
NuTech Medical
HQ: United States
Website
- Description: Provider of biologics for the general orthopedic and spine markets, offering anterior cervical plate systems, allograft interbody spacers, thoracolumbar pedicle screw systems, and NuShield Spine, a protective patch used as a barrier interface between the dura and surrounding musculature.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuTech Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MiMedx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MiMedx
2.2 - Growth funds investing in similar companies to MiMedx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MiMedx
4.2 - Public trading comparable groups for MiMedx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →